142 related articles for article (PubMed ID: 19021593)
21. A 2-yr national population study of pediatric ketoacidosis in Sweden: predisposing conditions and insulin pump use.
Hanas R; Lindgren F; Lindblad B
Pediatr Diabetes; 2009 Feb; 10(1):33-7. PubMed ID: 18761647
[TBL] [Abstract][Full Text] [Related]
22. Development of optimal kids insulin dosing system formulas for young children with type 1 diabetes mellitus.
Alemzadeh R; Hoffmann RG; Dasgupta M; Parton E
Diabetes Technol Ther; 2012 May; 14(5):418-22. PubMed ID: 22239470
[TBL] [Abstract][Full Text] [Related]
23. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: a meta-analysis.
Monami M; Lamanna C; Marchionni N; Mannucci E
Exp Clin Endocrinol Diabetes; 2009 May; 117(5):220-2. PubMed ID: 19301231
[TBL] [Abstract][Full Text] [Related]
24. Effect of nicotinamide on newly diagnosed type 1 diabetic children.
Kamal M; Abbasy AJ; Muslemani AA; Bener A
Acta Pharmacol Sin; 2006 Jun; 27(6):724-7. PubMed ID: 16723091
[TBL] [Abstract][Full Text] [Related]
25. [Low birth weight is a risk factor for type 1 diabetes].
García Cuartero B; González Vergaz A; Herranz S; Vázquez MC; Carvajal O; Carpintero P; Gutierrez P
An Pediatr (Barc); 2009 Jun; 70(6):542-6. PubMed ID: 19446512
[TBL] [Abstract][Full Text] [Related]
26. Seeking the factors predisposing to local skin inflammatory state development in children with type 1 diabetes (T1DM) treated with continuous subcutaneous insulin infusion (CSII).
Jarosz-Chobot P; Nowakowska M; Polanska J
Exp Clin Endocrinol Diabetes; 2007 Mar; 115(3):179-81. PubMed ID: 17427107
[TBL] [Abstract][Full Text] [Related]
27. Nationwide survey to compare the prevalence of transient elevation of liver transaminase during treatment of diabetic ketosis or ketoacidosis in new-onset acute and fulminant type 1 diabetes mellitus.
Takaike H; Uchigata Y; Iwamoto Y; Imagawa A; Iwahashi H; Kanatsuka A; Kawasaki E; Kobayashi T; Shimada A; Shimizu I; Maruyama T; Hanafusa T; Makino H
Ann Med; 2008; 40(5):395-400. PubMed ID: 18484350
[TBL] [Abstract][Full Text] [Related]
28. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
[TBL] [Abstract][Full Text] [Related]
29. Basal rates and circadian profiles in continuous subcutaneous insulin infusion (CSII) differ for preschool children, prepubertal children, adolescents and young adults.
Bachran R; Beyer P; Klinkert C; Heidtmann B; Rosenbauer J; Holl RW; ; ;
Pediatr Diabetes; 2012 Feb; 13(1):1-5. PubMed ID: 21545675
[TBL] [Abstract][Full Text] [Related]
30. Dermatological side effects and complications of continuous subcutaneous insulin infusion in preschool-age and school-age children.
Schober E; Rami B
Pediatr Diabetes; 2009 May; 10(3):198-201. PubMed ID: 19175897
[TBL] [Abstract][Full Text] [Related]
31. Treatment of diabetes mellitus using an external insulin pump in clinical practice.
Jeandidier N; Riveline JP; Tubiana-Rufi N; Vambergue A; Catargi B; Melki V; Charpentier G; Guerci B
Diabetes Metab; 2008 Sep; 34(4 Pt 2):425-38. PubMed ID: 18951117
[TBL] [Abstract][Full Text] [Related]
32. Macrosomia in well controlled CSII treated Type I diabetic pregnancy.
Cohen O; Keidar N; Simchen M; Weisz B; Dolitsky M; Sivan E
Gynecol Endocrinol; 2008 Nov; 24(11):611-3. PubMed ID: 19031216
[TBL] [Abstract][Full Text] [Related]
33. The use of insulin pumps improves the metabolic control in children and adolescents with type 1 diabetes.
Toni S; Reali MF; Fasulo A; Festini P; Medici A; Martinucci ME
Arch Dis Child; 2004 Aug; 89(8):796-7. PubMed ID: 15269092
[No Abstract] [Full Text] [Related]
34. [Evaluating the feature of hypoglycemia detected by continuous glucose monitoring system during temporary continuous subcutaneous insulin infusion in type 2 diabetes patients].
Li M; Zhou J; Bo YQ; Lu W; Jia WP; Xiang KS
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1679-82. PubMed ID: 19024537
[TBL] [Abstract][Full Text] [Related]
35. Clinical manifestations and beta cell function in Swedish diabetic children have remained unchanged during the last 25 years.
Nordwall M; Ludvigsson J
Diabetes Metab Res Rev; 2008 Sep; 24(6):472-9. PubMed ID: 18613248
[TBL] [Abstract][Full Text] [Related]
36. [Type 1 diabetes in children and adolescents--new strategies in management and treatment].
Kordonouri O; von Schütz W; Meyer N; Aschemeier B; Kracht T; Danne T
Med Monatsschr Pharm; 2008 Jun; 31(6):200-6; quiz 207-8. PubMed ID: 18661909
[TBL] [Abstract][Full Text] [Related]
37. A comparison of glycaemic variability in CSII vs. MDI treated type 1 diabetic patients using CGMS.
Simon B; Treat V; Marco C; Rosenberg D; Joseph J; Hipszer B; Li Y; Chervoneva I; Padron-Massara L; Jabbour S
Int J Clin Pract; 2008 Dec; 62(12):1858-63. PubMed ID: 19166434
[TBL] [Abstract][Full Text] [Related]
38. Evidence-based insulin treatment in type 1 diabetes mellitus.
Jacobsen IB; Henriksen JE; Hother-Nielsen O; Vach W; Beck-Nielsen H
Diabetes Res Clin Pract; 2009 Oct; 86(1):1-10. PubMed ID: 19647887
[TBL] [Abstract][Full Text] [Related]
39. Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy.
Bruttomesso D; Costa S; Baritussio A
Diabetes Metab Res Rev; 2009 Feb; 25(2):99-111. PubMed ID: 19172576
[TBL] [Abstract][Full Text] [Related]
40. [Insulin treatment in children].
Birkebaek NH; Hertz B; Olsen BS
Ugeskr Laeger; 2009 Jun; 171(23):1919-22. PubMed ID: 19500514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
